At this year’s meeting of the European Association for the Study of Diabetes, researchers reported that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in people with poorly controlled Type 1 diabetes.
The JDRF-funded study included 44 men and 42 women with Type 1 diabetes and randomly assigned them to receive treatment with an insulin pump and a continuous glucose monitor or a closed-loop insulin delivery system.
Get the full story at our sister site, Drug Delivery Business News.